127 related articles for article (PubMed ID: 8921948)
1. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
[TBL] [Abstract][Full Text] [Related]
2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
4. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
5. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
[TBL] [Abstract][Full Text] [Related]
6. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.
Saruhan-Direskeneli G; Weber F; Meinl E; Pette M; Giegerich G; Hinkkanen A; Epplen JT; Hohlfeld R; Wekerle H
Eur J Immunol; 1993 Feb; 23(2):530-6. PubMed ID: 7679649
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein.
Ausubel LJ; Bieganowska KD; Hafler DA
Cell Immunol; 1999 Apr; 193(1):99-107. PubMed ID: 10202117
[TBL] [Abstract][Full Text] [Related]
8. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99.
Ausubel LJ; Krieger JI; Hafler DA
J Immunol; 1997 Sep; 159(5):2502-12. PubMed ID: 9278344
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
[TBL] [Abstract][Full Text] [Related]
10. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
[TBL] [Abstract][Full Text] [Related]
11. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
[TBL] [Abstract][Full Text] [Related]
12. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
[TBL] [Abstract][Full Text] [Related]
13. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.
Wucherpfennig KW; Zhang J; Witek C; Matsui M; Modabber Y; Ota K; Hafler DA
J Immunol; 1994 Jun; 152(11):5581-92. PubMed ID: 7514641
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
15. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
16. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes.
Giegerich G; Pette M; Meinl E; Epplen JT; Wekerle H; Hinkkanen A
Eur J Immunol; 1992 Mar; 22(3):753-8. PubMed ID: 1372258
[TBL] [Abstract][Full Text] [Related]
17. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
[TBL] [Abstract][Full Text] [Related]
18. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
